Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28713

1.

Effect of Lipidated Gonadotropin-Releasing Hormone Peptides on Receptor Mediated Binding and Uptake into Prostate Cancer Cells in Vitro.

Stephenson R, Varamini P, Butcher N, Minchin R, Toth I.

Nanomedicine. 2014 Jul 8. pii: S1549-9634(14)00328-1. doi: 10.1016/j.nano.2014.06.015. [Epub ahead of print]

PMID:
25014892
[PubMed - as supplied by publisher]
2.

Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma.

Park YA, Choi CH, Do IG, Song SY, Lee JK, Cho YJ, Choi JJ, Jeon HK, Ryu JY, Lee YY, Kim TJ, Bae DS, Lee JW, Kim BG.

Gynecol Oncol. 2014 Jul 8. pii: S0090-8258(14)01072-5. doi: 10.1016/j.ygyno.2014.06.031. [Epub ahead of print]

PMID:
25014541
[PubMed - as supplied by publisher]
3.

Facile, Regio- and Diastereoselective Synthesis of Spiro-Pyrrolidine and Pyrrolizine Derivatives and Evaluation of Their Antiproliferative Activities.

Almansour AI, Kumar RS, Beevi F, Shirazi AN, Osman H, Ismail R, Choon TS, Sullivan B, McCaffrey K, Nahhas A, Parang K, Ali MA.

Molecules. 2014 Jul 10;19(7):10033-10055.

PMID:
25014532
[PubMed - as supplied by publisher]
4.

Real-time Immuno-polymerase chain reaction in 384-well format: detection of VEGF and EGFL7.

Zhang J, Vernes JM, Ni J, Nelson C, Wong A, Chen ST, Asundi A, Vandlen R, Gloria Meng Y.

Anal Biochem. 2014 Jul 8. pii: S0003-2697(14)00283-8. doi: 10.1016/j.ab.2014.06.024. [Epub ahead of print]

PMID:
25013989
[PubMed - as supplied by publisher]
5.

COX-2 expression pattern is related to ovarian cancer differentiation and prognosis, but is not consistent with new model of pathogenesis.

Magnowska M, Zaborowski M, Surowiak P, Nowak-Markwitz E, Zabel M, Spaczyński M.

Ginekol Pol. 2014 May;85(5):335-41.

PMID:
25011213
[PubMed - in process]
6.

Methylseleninic Acid Sensitizes Notch3-Activated OVCA429 Ovarian Cancer Cells to Carboplatin.

Tzeng TJ, Cao L, Fu Y, Zeng H, Cheng WH.

PLoS One. 2014 Jul 10;9(7):e101664. doi: 10.1371/journal.pone.0101664. eCollection 2014.

PMID:
25010594
[PubMed - in process]
7.

MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET.

Sheng XJ, Li Z, Sun M, Wang ZH, Zhou DM, Li JQ, Zhao Q, Sun XF, Liu QC.

Oncol Lett. 2014 Aug;8(2):891-897. Epub 2014 May 27.

PMID:
25009663
[PubMed]
8.

Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa.

Tyszkiewicz T, Jarzab M, Szymczyk C, Kowal M, Krajewska J, Jaworska M, Fraczek M, Krajewska A, Hadas E, Swierniak M, Markowski J, Lange D, Poltorak S, Wiench M, Krecicki T, Jarzab J, Maciejewski A.

Folia Histochem Cytobiol. 2014;52(2):79-89. doi: 10.5603/FHC.2014.0018.

PMID:
25007175
[PubMed - in process]
Free Article
9.

Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge.

Pandey A, Bhosale B, Pandita V, Singh A, Ghosh J, Ghosh J, Bajpai J.

Indian J Med Paediatr Oncol. 2014 Jan;35(1):17-20. doi: 10.4103/0971-5851.133705. Review.

PMID:
25006278
[PubMed]
Free PMC Article
10.

Follicle-stimulating hormone polypeptide in treatment of lymphatic metastasis during ovarian carcinoma therapy via nanopariticle drug delivery system.

Fan L, Chen J, Zhang X, Liu Y, Xu C.

Gynecol Oncol. 2014 Jul 5. pii: S0090-8258(14)01071-3. doi: 10.1016/j.ygyno.2014.06.030. [Epub ahead of print]

PMID:
25003656
[PubMed - as supplied by publisher]
11.

Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines.

Davidson BA, Rubatt JM, Corcoran DL, Teoh DK, Bernardini MQ, Grace LA, Soper WJ, Berchuck A, Siamakpour-Reihani S, Chen W, Owzar K, Murphy SK, Secord AA.

Front Oncol. 2014 Jun 20;4:163. doi: 10.3389/fonc.2014.00163. eCollection 2014.

PMID:
24999452
[PubMed]
Free PMC Article
12.

Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.

Desjardins M, Xie J, Gurler H, Muralidhar GG, Sacks JD, Burdette JE, Barbolina MV.

J Ovarian Res. 2014 Jun 26;7:70. doi: 10.1186/1757-2215-7-70. eCollection 2014.

PMID:
24999371
[PubMed - in process]
Free PMC Article
13.

Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen.

Chene G, Radosevic-Robin N, Tardieu AS, Cayre A, Raoelfils I, Dechelotte P, Dauplat J, Penault Llorca F.

Eur J Histochem. 2014 Apr 15;58(2):2251. doi: 10.4081/ejh.2014.2251.

PMID:
24998918
[PubMed - in process]
Free PMC Article
14.

Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinoma.

Cohen S, Mosig R, Moshier E, Pereira E, Rahaman J, Prasad-Hayes M, Halpert R, Billaud JN, Dottino P, Martignetti JA.

Gynecol Oncol. 2014 Jul 1. pii: S0090-8258(14)01066-X. doi: 10.1016/j.ygyno.2014.06.025. [Epub ahead of print]

PMID:
24995581
[PubMed - as supplied by publisher]
15.

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer.

Mitchell PL, Quinn MA, Grant PT, Allen DG, Jobling TW, White SC, Zhao A, Karanikas V, Vaughan H, Pietersz G, McKenzie IF, Gargosky SE, Loveland BE.

J Immunother Cancer. 2014 Jun 18;2:16. doi: 10.1186/2051-1426-2-16. eCollection 2014.

PMID:
24995129
[PubMed]
Free PMC Article
16.

[Endometriosis-related ovarian tumors].

Schmidt D, Ulrich U.

Pathologe. 2014 Jul;35(4):348-54. doi: 10.1007/s00292-014-1949-4. German.

PMID:
24992974
[PubMed - in process]
17.

GPC3 expression in mouse ovarian cancer induces GPC3‑specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth.

Luo C, Shibata K, Suzuki S, Kajiyama H, Senga T, Koya Y, Daimon M, Yamashita M, Kikkawa F.

Oncol Rep. 2014 Jul 2. doi: 10.3892/or.2014.3300. [Epub ahead of print]

PMID:
24992906
[PubMed - as supplied by publisher]
18.

BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer.

Sugio A, Iwasaki M, Habata S, Mariya T, Suzuki M, Osogami H, Tamate M, Tanaka R, Saito T.

Gynecol Oncol. 2014 Jun 30. pii: S0090-8258(14)01065-8. doi: 10.1016/j.ygyno.2014.06.024. [Epub ahead of print]

PMID:
24992675
[PubMed - as supplied by publisher]
19.

PAX2 and PAX8 Reliably Distinguishes Ovarian Serous Tumors From Mucinous Tumors.

Wang M, Ma H, Pan Y, Xiao W, Li J, Yu J, He J.

Appl Immunohistochem Mol Morphol. 2014 Jul 2. [Epub ahead of print]

PMID:
24992169
[PubMed - as supplied by publisher]
20.

DNA Damage Signaling and Apoptosis in Preinvasive Tubal Lesions of Ovarian Carcinoma.

Chene G, Ouellet V, Rahimi K, Barres V, Caceres K, Meunier L, Cyr L, De Ladurantaye M, Provencher D, Mes Masson AM.

Int J Gynecol Cancer. 2014 Jul 1. [Epub ahead of print]

PMID:
24987917
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk